|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Alzheimer Disease | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Delirium, Dementia, Amnestic, Cognitive Disorders | |||||
| Dementia | |||||
| Mental Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Tauopathies | |||||
| 3 | Interventions listed in this trial | ||||
| Donepezil | |||||
| Vitamin E | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Alpha-Tocopherol | |||||
| Tocopherol acetate | |||||
| Tocopherols | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Central Nervous System Agents | |||||
| Cholinergic Agents | |||||
| Cholinesterase Inhibitors | |||||
| Enzyme Inhibitors | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Nootropic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Therapeutic Uses | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute on Aging (NIA) | |||||